Uptake and Efflux of Quinacrine, a Candidate for the Treatment of Prion Diseases, at the Blood-Brain Barrier
- 1 April 2004
- journal article
- Published by Springer Science and Business Media LLC in Cellular and Molecular Neurobiology
- Vol. 24 (2), 205-217
- https://doi.org/10.1023/b:cemn.0000018617.21378.95
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Molecular cloning and functional characterization of the OCTN2 transporter at the RBE4 cells, an in vitro model of the blood–brain barrierBrain Research, 2003
- Structural and functional characteristics and tissue distribution pattern of rat OCTN1, an organic cation transporter, cloned from placentaBiochimica et Biophysica Acta (BBA) - Biomembranes, 2000
- rOCT2 is a basolateral potential-driven carrier, not an organic cation/proton exchangerAmerican Journal of Physiology-Renal Physiology, 1999
- Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter.1999
- Organic cation transport in rat choroid plexus cells studied by fluorescence microscopyAmerican Journal of Physiology-Cell Physiology, 1999
- ORGANIC CATION TRANSPORTERS IN INTESTINE, KIDNEY, LIVER, AND BRAINAnnual Review of Physiology, 1998
- Cloning and characterization of a novel human pH‐dependent organic cation transporter, OCTN1FEBS Letters, 1997
- Cloning and Characterization of Two Human Polyspecific Organic Cation TransportersDNA and Cell Biology, 1997
- Mechanisms of Sodium Transport at the Blood‐Brain Barrier Studied with In Situ Perfusion of Rat BrainJournal of Neurochemistry, 1996
- Drug Transfer Across the Blood‐Brain Barrier: Correlation Between In Vitro and In Vivo ModelsJournal of Neurochemistry, 1992